AVIDIN KFT has a total of 14 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Hungary, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PFIZER RES AND DEV CO NV SA, CHEN SHOUJUN and VERTEKS FARMAS JUTIKALZ INKORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Hungary | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Puskas Laszlo | 6 |
#2 | Puskas Laszlo Dr | 5 |
#3 | Ozsvari Bela Dr | 5 |
#4 | Molnar Eszter | 5 |
#5 | Feher Liliana | 5 |
#6 | Kanizsai Ivan Dr | 3 |
#7 | Nagy Lajos Istvan | 3 |
#8 | Gyuris Mario | 3 |
#9 | Hajszan Tibor Dr | 2 |
#10 | Feher Liliana Dr | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019220155A1 | Imidazo-pyrazole carboxamide derivatives as anticancer agents and the synthesis thereof | |
HU1500098A2 | New enantiomers of 8-hydroxyquinoline derivatives and their synthesis | |
HU1100723A2 | Use of estrogen derivatives for preparing medicament for the treatment of psychiatric diseases | |
HU1100532A2 | Substituted curcumin derivatives, process for their preparation, and pharmaceutical compositions containing them | |
HU1000688D0 | Use of trifluoro-phthalimides in the treatment of cancer | |
HU1000335D0 | Use of an estrogen derivative for the treatment and/or prevention of psychiatric conditions | |
HU1000284D0 | Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation | |
HU1000243D0 | 8-hidroxy-quinoline derivatives | |
CN101784523A | Novel compounds, compounds that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |